XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCK BASED AWARD PLANS (Tables)
9 Months Ended
Sep. 30, 2022
Compensation plans:  
Schedule of ESPP valuation assumptions

Offering Period Ending

11/30/2022

11/30/2021

Fair market value of common stock

$

11.16

$

19.89

Volatility

 

35.4

%

 

35.1

%

Expected term (years)

 

0.5

 

0.5

Expected dividend yield

 

-

%

 

-

%

Risk-free interest rate

 

1.6

%

 

0.1

%

Schedule of stock-based compensation cost related to incentive awards

For the three months ended September 30, 

For the nine months ended September 30, 

2022

    

2021

    

2022

    

2021

(unaudited)

(unaudited)

Stock-based compensation expense:

Stock options

$

1,836

$

5,579

$

5,250

$

13,260

RSUs

 

2,544

 

908

 

6,665

 

2,137

RSAs

725

799

2,034

4,454

ESPP

 

151

 

136

 

434

 

399

Total stock-based compensation expense

$

5,256

$

7,422

$

14,383

$

20,250

Schedule of stock based compensation cost in consolidated statement of operations

For the three months ended September 30, 

For the nine months ended September 30, 

2022

    

2021

    

2022

    

2021

(unaudited)

(unaudited)

Stock-based compensation expense:

Cost of revenues, software subscriptions

$

577

$

656

$

1,502

$

1,788

Cost of revenues, services

 

374

 

760

 

1,055

 

1,976

Research and development

 

581

 

876

 

1,193

 

2,008

Selling and marketing

 

1,621

 

2,157

 

4,594

 

4,877

General and administrative

 

2,103

 

2,973

 

6,039

 

9,601

Total stock-based compensation expense

$

5,256

$

7,422

$

14,383

$

20,250

Stock options  
Compensation plans:  
Schedule of Option activity

Weighted

Weighted

Average

Average

Remaining

Aggregate

Exercise

Contractual

Intrinsic

2020 Plan Option Activity

Units

Price

Life (Years)

Value

(unaudited)

Outstanding at January 1, 2022

9,500

$

4.20

5.2

$

110,843

Forfeited

(100)

5.31

Expired

(1)

32.16

Exercised

(668)

2.81

2020 Plan options outstanding at September 30, 2022

8,731

4.29

4.5

81,881

2020 Plan options excercisable at September 30, 2022

6,294

2.80

3.5

68,410

Schedule of outstanding, vested and exercisable

Options Outstanding

Options Vested and Exercisable

    

    

Weighted

    

    

Weighted

Average

Average

Exercise Prices

Units

Life (Years)

Units

Life (Years)

(unaudited)

$0.15 to $0.71

 

1,766

 

 

1,766

 

$2.15

 

336

 

2.4

 

336

 

1.4

$2.50

 

2,161

 

3.8

 

2,161

 

3.8

$2.67

 

419

 

4.4

 

419

 

4.4

$3.17

 

1,074

 

5.5

 

322

 

5.6

$3.73

1,533

7.1

756

7.1

$4.70

683

7.4

341

7.4

$18.47

213

9.2

$18.96

235

8.9

105

8.9

$19.00

 

66

 

9.0

 

17

 

9

$32.16

 

245

 

8.4

 

71

 

7.6

 

8,731

 

6,294

Schedule of valuation assumptions

Option Valuation Period

Q3 2021

    

 

Q3 2021

    

 

Q2 2021

    

 

Q1 2021

    

Fair market value of common stock

$

18.96

 

$

19.00

 

$

17.66

 

$

32.16

Volatility

 

 

37.1

%

 

 

37.1

%

 

 

36.8

%

 

 

36.8

%

Expected term (years)

 

 

5.0

 

5.0

 

6.0

 

6.0

Expected dividend yield

 

 

%

 

%

 

%

 

%

Risk-free interest rate

 

 

0.8

%

 

0.9

%

 

0.4

%

 

0.4

%

Restricted Stock Units  
Compensation plans:  
Schedule of Option activity

    

    

    

Weighted

Average

Grant Date Fair

Units

Value Per Share

Outstanding at January 1, 2022

530

$

26.49

Granted

2,128

13.43

Vested

(48)

23.33

Forfeited

(118)

15.93

Outstanding at September 30, 2022

2,492

$

15.90

Restricted Stock Awards  
Compensation plans:  
Schedule of restricted activity

    

Weighted

Average

Grant Date Fair

Units

Value Per Share

Outstanding at January 1, 2022

326

$

18.76

Granted

106

9.92

Vested

(188)

18.58

Forfeited

(9)

19.00

Outstanding at September 30, 2022

235

$

14.91